Cancer survivor highlights importance of clinical trials for treatment advancement
A cancer survivor, known as Patient 3737, shares her experience with clinical trials that saved her life after standard treatments failed. She emphasizes that trials are not just a last resort but vital for advancing cancer treatment. Despite the potential benefits, only 5-7% of adult cancer patients participate in clinical trials. Barriers such as misconceptions, geographic limitations, and financial concerns prevent many from enrolling, particularly those from underrepresented communities. The Cholangiocarcinoma Foundation aims to increase awareness and participation in clinical trials. They focus on debunking myths and improving access, advocating for education among patients and healthcare providers to enhance treatment options for all.